Occulogix Inc., doing business as TearLab Corp., presented the poster, 'Osmolarity as a biomarker for disease severity in mild to moderate dry eye disease,' from the TearLab osmolarity core validation study today at the 2009
American Academy of Ophthalmology ...
[Stockwatch - 10/26/2009]